PhRMA Senses Wood Is Close To FDA Nomination; Sundwall Interviewed
This article was originally published in The Tan Sheet
Executive Summary
The Pharmaceutical Research & Manufacturers of America is advising its members to look carefully at the background and published positions of Vanderbilt's Alastair Wood, MD, as the White House moves closer to a nomination for the post of FDA commissioner
You may also be interested in...
‘Emotional’ NDACs Stymie OTC Switches – Former Chairman Wood
OTC industry stakeholders must prepare better for FDA Nonprescription Drug Advisory Committee meetings and argue against members’ “emotional” objections to switches based on retail price or loss of doctor-patient visits, says former NDAC chair Alistair Wood.
‘Emotional’ NDACs Stymie OTC Switches – Former Chairman Wood
OTC industry stakeholders must prepare better for FDA Nonprescription Drug Advisory Committee meetings and argue against members’ “emotional” objections to switches based on retail price or loss of doctor-patient visits, says former NDAC chair Alistair Wood.
‘Emotional’ NDACs Stymie OTC Switches – Former Chairman Wood
OTC industry stakeholders must prepare better for FDA Nonprescription Drug Advisory Committee meetings and argue against members’ “emotional” objections to switches based on retail price or loss of doctor-patient visits, says former NDAC chair Alistair Wood.